Today's Date: April 29, 2024
Plant Vogtle Unit 4 Achieves Commercial Operations   •   Designer Secret Revealed: aerMist Misters Enhance Outdoor Living Spaces   •   Ten Pennsylvania Communities Selected to Participate in Community Revitalization Initiative   •   Cooler Master Unveils New CALIBER X2C and R3C Gaming Chairs for the Ultimate Cool Comfort   •   Struck by Lightning: How Businesses Can Become More Resilient – Triple-I and LPI   •   USPAACC Announces CelebrASIAN 2024 Procurement + Business Conference, May 29-31, The Hotel at Avalon, Autograph Collection, Alph   •   Enter to Win Florida Realtors® ENVY Award   •   Natron Energy Achieves First-Ever Commercial-Scale Production of Sodium-Ion Batteries in the U.S.   •   Soleo Health Unveils Pharmacy in Jackson, MS; Marks Pharmacy Entry Into State   •   InventHelp Inventor Develops New Religious-Themed Game (BRK-4269)   •   MoPOP Announces Revamped Volunteer Program With Exclusive Benefits   •   Yamaha Publicly Demonstrates Yamaha Hydrogen-Powered Golf Car for First Time   •   Atavus Football Announces Strategic Partnership with Hudl, Becoming an Official Preferred Partner   •   Health-E Commerce® shares 5 ways to use FSA or HSA funds to support women's health   •   Disney Celebrates World Wish Day ® by Granting Over One Hundred Wishes Around the World   •   SHATTERPROOF AND ANTHEM BLUE CROSS AND BLUE SHIELD FOUNDATION PARTNER TO REDUCE HEALTHCARE STIGMA AROUND SUBSTANCE USE DISORDER   •   Sallie Mae Releases Environmental, Social, and Governance (ESG) Report   •   New Perspective closes on more than $200 Million in capital and establishes a programmatic relationship for growth   •   Union Pacific Highlights Commitment to Safety, Community and Sustainability in 2023 Building America Report   •   CHOP Study Finds Healthcare Providers Play Crucial Role in Guiding Autistic Adolescents and Their Families into Adulthood
Bookmark and Share

MISTR, Known for its Free Online PrEP and Long-Term HIV Care, is Now Prescribing DoxyPEP

LOS ANGELES , April 16 /Businesswire/ - MISTR, the largest telemedicine provider offering free online PrEP and long-term HIV care in all 50 states, D.C., and Puerto Rico, is now prescribing Doxycycline Post-Exposure Prophylaxis (DoxyPEP), an antibiotic that reduces bacterial STIs, including gonorrhea, chlamydia, and syphilis. Beginning today, patients can now use MISTR’s seamless telehealth platform to receive DoxyPEP online for free.

With this launch, MISTR plans to further solve the issue of access and adherence to PrEP and HIV care, and now offers patients access to post-exposure care, in addition to their existing preventive and long-term HIV treatment options, which include PrEP and antiretroviral therapy (ART). This comes at a time when the rate of STIs continue to rise - in 2022, more than 2.5 million cases of syphilis, gonorrhea, and chlamydia were reported in the U.S.; of that population, gay and bisexual men are disproportionately affected.

“Despite an ongoing STI epidemic affecting the LGBTQ+ community, there are few resources available for this underserved, vulnerable community to get the preventative medication they need,” said Tristan Schukraft, CEO and Founder of MISTR. “I’m proud that MISTR is democratizing access to PrEP, HIV Care, and now DoxyPEP.”

DoxyPEP has already shown promising results in reducing the rates of certain STIs. An NIH-funded study published by the New England Journal of Medicine in April 2023 found that doxycycline as post-exposure prophylaxis, now known as DoxyPEP, reduced syphilis by 87%, chlamydia by 88%, and gonorrhea by 55% in individuals taking HIV PrEP, and reduced syphilis by 77%, chlamydia by 74% and gonorrhea by 57% in people living with HIV. Now MISTR patients can receive DoxyPEP, in addition to their PrEP or HIV care medications.

This launch comes on the heels of immense growth for MISTR, with over 300,000 patients served. The company has plans to further expand their product portfolio in 2024, and open the doors to their MISTR storefronts. To learn more about MISTR, visit mistr.com.

ABOUT MISTR:

MISTR is a telemedicine platform offering free online access to pre-exposure prophylaxis (PrEP) and long-term HIV care in all 50 states, D.C. and Puerto Rico. Gay owned and operated, MISTR has brought together a network of the best doctors, pharmacists, and problem solvers to make PrEP, DoxyPEP and long-term HIV care available to all who need it. No doctor’s office, no paperwork and free delivery. Visit www.mistr.com.


STORY TAGS: Product/Service, United States, North America, Telemedicine/Virtual Medicine, Other Health, Pharmaceutical, Other Consumer, General Health, Philanthropy, Women, Infectious Diseases, Men, LGBTQ+, Other Philanthropy, AIDS, Lifestyle, Consumer, Health, California,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News